Michael Scolaro

Michael Scolaro

Oct 07, 2017

Group 6 Copy 216
1
Please wait...

About This Project

We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

Blast off!

Browse Other Projects on Experiment

Related Projects

Antibiotics and Affect: Avenues for Addiction Management

Addictions to cocaine and other stimulant 'designer' drugs remain unaided by pharmacotherapies. Several...

Gene therapy against vision loss in the elderly

Retinal pigment epithelium (RPE) degeneration is a key feature of age-related macular degeneration (AMD...

How good are North American mosquitoes at spreading Zika virus?

Zika virus (ZIKV) is usually transmitted by Aedes mosquitoes. In different geographic locations...

Backer Badge Funded